15 completed, 3 active not recruiting, 2 unknown, 1 recruiting. 23 Phase 3, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 23 | Completed 15, Active not recruiting 3, Unknown 2, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 9 | Completed 5, Active not recruiting 2, Unknown 2 |
Follow Mild Cognitive Impairment: new trials by email Literature Review of Mild Cognitive Impairment trials Research Report on Mild Cognitive Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study) Mazdutide, Placebo - Dementia, Mild, Mild Cognitive Impairment | Phase 3 | Recruiting | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 420 | 2025-09-27 | 2026-09-02 |
| Study on Ginkgo Biolba Extract Fifty and Mild Cognitive Impairment Associated With CSVD Ginkgo biloba extract 50 dropping pills, Ginkgo biloba extract Ginkgo biloba extract 50 Drops simulant - Mild Cognitive Impairment | Phase 2 / Phase 3 | Active not recruiting | Beijing Tiantan Hospital | 144 | 2024-09-27 | 2026-10-08 |
| Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment Precision Medicine Approach, Hormones and Medications tailored to lab tests, combined with devices that support stress management and brain exercises, Standard-of-Care - Mild Cognitive Impairment, Dementia, Mild | Phase 3 | Completed | Alzheimer's Prevention and Reversal Project, Inc. | 73 | 2023-07-31 | 2026-02-18 |
| ACHIEVE Brain Health Follow-Up Study Hearing intervention, Successful aging/delayed hearing intervention - Aging, Cognitive Decline | Phase 3 | Active not recruiting | Johns Hopkins University | 629 | 2023-01-12 | 2026-07-21 |
| Metformin in Alzheimer's Dementia Prevention Placebo oral tablet, extended release metformin - Mild Cognitive Impairment | Phase 2 / Phase 3 | Active not recruiting | Columbia University | 326 | 2021-03-22 | 2026-08-11 |
| Dapagliflozin Effect in Cognitive Impairment in Stroke Trial Dapagliflozin 10mg Tab, Statins (Cardiovascular Agents), Platelet Antiaggregant - Stroke, Ischemic, Mild Cognitive Impairment | Phase 2 / Phase 3 | Unknown | Jaime Daniel Mondragon | 270 | 2020-08-01 | 2022-10-04 |
| Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease Placebo Oral Tablet, AGB101 220 mg tablet - Mild Cognitive Impairment, Prodromal Alzheimer's Disease | Phase 2 / Phase 3 | Completed | AgeneBio | 164 | 2018-12-13 | 2024-05-17 |
| Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type Renew NCP-5 - Alzheimer Disease, Cognitive Dysfunction | Phase 3 | Completed | Renew Research, LLC | 190 | 2018-11-12 | 2022-05-11 |
| Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Early Recovery Stage After Ischemic Stroke MMH-MAP, Placebo - Mild Cognitive Impairment, Ischemic Stroke | Phase 3 | Completed | Materia Medica Holding | 276 | 2018-10-19 | 2021-02-23 |
| The Combination of Donepezil and Cognitive Training for Treating Alcohol Use Disorder Donepazil - Alcohol Use Disorder, Mild Cognitive Impairment | Phase 2 / Phase 3 | Completed | VA Connecticut Healthcare System | 15 | 2018-08-17 | 2020-03-24 |
| Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II Amyloid imaging, FDG-PET - Mild Cognitive Impairment | Phase 3 | Withdrawn | University of California, Los Angeles | 2018-06-01 | 2018-10-15 | |
| The Healthy Patterns Sleep Study Attention-Control Condition, Timed Activity Intervention - Dementia, Alzheimer Disease | Phase 3 | Completed | University of Pennsylvania | 421 | 2016-05-01 | 2024-07-26 |
| Investigating the Clinical Consequences of Flutemetamol-PET-scanning Flutemetamol (Vizamyl) - Mild Cognitive Impairment, Alzheimer's Disease | Phase 3 | Terminated | University of Zurich | 11 | 2015-05-01 | 2020-01-21 |
| Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia Period I MCET (8 wks), Washout (4 wks), Period II MCET (8 wks) - Mild Cognitive Impairment, Dementia, Mild | Phase 3 | Completed | Ki Woong Kim | 64 | 2014-02-01 | 2015-07-28 |
| DIetary Supplements, Executive funcTions and Vitamin D (DIET-D) Lecitone®Se-Vitamin D3, Placebo - Mild Cognitive Impairment | Phase 2 / Phase 3 | Unknown | University Hospital, Angers | 160 | 2012-11-01 | 2012-10-16 |
| A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) florbetapir (18F) - Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 / Phase 3 | Completed | Avid Radiopharmaceuticals | 48 | 2012-10-01 | 2013-09-19 |
| Efficacy of Ubiquitous SR-based Memory Advancement and Rehabilitation Training (U-SMART) Phase I U-SMART (4 wks), Washout (2 wks), Phase II U-SMART (4 wks) - Mild Cognitive Impairment | Phase 3 | Completed | Seoul National University Bundang Hospital | 50 | 2012-08-01 | 2016-04-20 |
| Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images [18F]Flutemetamol - Alzheimer's Disease, Mild Cognitive Impairment | Phase 3 | Completed | GE Healthcare | 276 | 2012-07-01 | 2014-01-24 |
| Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI) caloric restriction, omega-3 supplementation, resveratrol supplementation - Mild Cognitive Impairment | Phase 2 / Phase 3 | Completed | Charite University, Berlin, Germany | 330 | 2010-08-01 | 2017-07-28 |
| Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease Flutemetamol (18F) Injection - Mild Cognitive Impairment, Alzheimer's Disease | Phase 3 | Completed | GE Healthcare | 365 | 2009-12-01 | 2014-09-11 |
Showing 20 of 23. Sign in to see all of them.
Cognitive Dysfunction (23) · Alzheimer Disease (11) · Dementia (7) · Lymphoma, Follicular (3) · Dementia, Vascular (2) · Ischemic Stroke (2) · Alcoholism (1) · Anomia (1) · Chronobiology Disorders (1) · Communication Disorders (1) · Depression (1) · Depressive Disorder, Major (1) · Diabetes Mellitus, Type 2 (1) · Disorders of Excessive Somnolence (1) · Frontotemporal Dementia (1)
Cognition Disorders (23) · Mental Disorders (23) · Neurocognitive Disorders (22) · Brain Diseases (16) · Central Nervous System Diseases (16) · Nervous System Diseases (16) · Neurodegenerative Diseases (11) · Tauopathies (11) · Dementia (8) · Cardiovascular Diseases (4) · Cerebrovascular Disorders (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Vascular Diseases (4)
flutemetamol (3) · Aspirin (1) · Atorvastatin (1) · Biguanides (1) · Bromocriptine (1) · Caloric Restriction (1) · Cardiovascular Agents (1) · Clopidogrel (1) · Cognitive Training (1) · Donepezil (1) · Escitalopram (1) · Exercise (1) · Hormones (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Hypoglycemic Agents (1)
GE Healthcare (2) · AgeneBio (1) · Alzheimer's Prevention and Reversal Project, Inc. (1) · Avid Radiopharmaceuticals (1) · Beijing Tiantan Hospital (1) · Charite University, Berlin, Germany (1) · Columbia University (1) · Jaime Daniel Mondragon (1) · Johns Hopkins University (1) · Ki Woong Kim (1) · Materia Medica Holding (1) · New York State Psychiatric Institute (1) · North China Pharmaceutical Group Corporation (1) · Renew Research, LLC (1) · Seoul National University Bundang Hospital (1)
United States (10) · China (3) · South Korea (2) · Canada (1) · France (1) · Germany (1) · Ireland (1) · Japan (1) · Mexico (1) · Russia (1) · Singapore (1) · Switzerland (1)
Ki Woong Kim, M.D., Ph.D. (2) · Agnes Floeel, Prof. (1) · Billy Tally (1) · Christoph Hock, MD, Prof. (1) · Dale Bredesen, MD (1) · Daniel Silverman, MD, Ph.D. (1) · Davangere Devanand, M.D. (1) · Frank R Lin, MD, PhD (1) · Gregory Pelton, M.D. (1) · Jinzhou Tian, MD,PhD (1) · Josef Coresh, MD, PhD (1)
PMID 20204386, PMID 23040716, PMID 26433119, PMID 26559790, PMID 26912492, PMID 27037094, PMID 27511061, PMID 28095900, PMID 28326010, PMID 28587629, PMID 28596794, PMID 28950419, PMID 29016744, PMID 29336496, PMID 29371333, PMID 29379114, PMID 29446769, PMID 29573529, PMID 31236801, PMID 31248555, PMID 31535829, PMID 32115470, PMID 32144994, PMID 32178931, PMID 32317958, PMID 32352644, PMID 32559474, PMID 32854852, PMID 33030307, PMID 33282811, PMID 33853394, PMID 33894597, PMID 34344312, PMID 34813630, PMID 35351181, PMID 37203336
R01AG027156 (1), R01AG048349 (1), R01AG061091 (1), R01AG062624 (1), R01AG076518 (1), R01NR015226 (1), R56AG055416 (1)